Inozyme Company
Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.
Investors
Technology:
Data-driven Technologies
Industry:
Gene therapy
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
9
Total Funding:
150099989
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series A
Register and Claim Ownership